Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
Crossref DOI link: https://doi.org/10.1007/s00280-014-2536-3
Published Online: 2014-07-23
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiu, Chao-Hua
Chou, Teh-Ying
Chiang, Chi-Lu
Tsai, Chun-Ming
Text and Data Mining valid from 2014-07-23